Literature DB >> 11457515

Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates.

S Tanganelli1, K Fuxe, T Antonelli, W T O'Connor, L Ferraro.   

Abstract

The present article reviews our recent biochemical and microdialysis studies showing the evidence for an antagonistic CCK(B)/D(2) receptor interaction in the regulation of dopaminergic transmission in the nucleus accumbens and GABAergic transmission in the ipsilateral ventral pallidum. Since the nucleus accumbens plays a crucial role in regulating the output from the limbic system and consequently motivation, it may be speculated that a dysregulation of this receptor interaction may have consequences in a wide range of central nervous system disorders.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11457515     DOI： 10.1016/s0196-9781(01)00446-6

Source DB:  PubMed          Journal:  Peptides        ISSN： 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  The biochemical bases of the placebo effect.

Authors:  Raúl de la Fuente-Fernández; A Jon Stoessl
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

2.  Cholecystokinin selectively activates short axon cells to enhance inhibition of olfactory bulb output neurons.

Authors:  Xiang Liu; Shaolin Liu
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

3.  A cholecystokinin B receptor antagonist and cocaine interaction, phase I study.

Authors:  Ahmed Elkashef; James Robert Brašić; Louis R Cantelina; Roberta Kahn; Nora Chiang; Weiguo Ye; Yun Zhou; Jurij Mojsiak; Kimberly R Warren; Andrew Crabb; John Hilton; Dean F Wong; Frank Vocci
Journal:  CNS Neurosci Ther       Date:  2018-06-20       Impact factor: 5.243

4.  Delayed but not immediate effects of estrogen curtail gamma-aminobutyric acid-mediated feeding responses elicited from the nucleus accumbens shell.

Authors:  Julio C Diaz; Kate Dunaway; Elizabeth Sheil; Ken Sadeghian; Anthony Auger; Brian A Baldo
Journal:  Behav Neurosci       Date:  2022-04-07       Impact factor: 2.154

Review 5.  Hormones in the naso-oropharynx: endocrine modulation of taste and smell.

Authors:  Bronwen Martin; Stuart Maudsley; Caitlin M White; Josephine M Egan
Journal:  Trends Endocrinol Metab       Date:  2009-04-07       Impact factor: 12.015

6.  Hypothalamus-olfactory system crosstalk: orexin a immunostaining in mice.

Authors:  Jean Gascuel; Aleth Lemoine; Caroline Rigault; Frédérique Datiche; Alexandre Benani; Luc Penicaud; Laura Lopez-Mascaraque
Journal:  Front Neuroanat       Date:  2012-11-08       Impact factor: 3.856

7.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

8.  Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Zaida Diaz-Cabiale; Alicia Rivera; Luca Ferraro; Sergio Tanganelli; Alexander O Tarakanov; Pere Garriga; José Angel Narváez; Francisco Ciruela; Michele Guescini; Luigi F Agnati
Journal:  Front Physiol       Date:  2012-06-04       Impact factor: 4.566

9.  Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.

Authors:  Hailei Yu; Di Wen; Chunling Ma; Yanxin Meng; Shujin Li; Zhiyu Ni; Bin Cong
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralization.

Authors:  Sebastian Ocklenburg; Larissa Arning; Wanda M Gerding; Jörg T Epplen; Onur Güntürkün; Christian Beste
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.